The effect of micro-particle curcumin on chronic kidney disease progression: the MPAC-CKD randomized clinical trial.

Matthew A WeirMichael WalshMeaghan S CuerdenJessica M SontropBradley L UrquhartYong Jin LimLaura C ChambersAmit X Garg

Published in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2023)

Ninety milligrams of micro-particle curcumin daily did not slow the progression of albuminuric chronic kidney disease over six months. Trial Registration: ClinicalTrials.gov Identifier: NCT02369549.

Keyphrases

chronic kidney disease
end stage renal disease
clinical trial
phase iii
phase ii
randomized controlled trial
peritoneal dialysis
open label